Jefferson researchers use gene therapy for rare, inherited brain disease
A team of scientists, neurosurgeons and physicians at Thomas Jefferson University Hospital are for the first time using a novel form of gene therapy for Canavan disease, a fatal, neurodegenerative childhood disorder. Armed with a new $2.1 million, three-year NIH grant, researchers recently introduced 90 billion copies of a healthy gene into the brains of three children. Their brains lacked the gene, which makes an enzyme that breaks down an acid substance in the brain.
National Institute of Neurological Disease and Stroke
Thomas Jefferson University
Message posted by: Wouter Kalle
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking